Patent · US Active

Inhibiting GS-FDH to modulate no bioactivity

US8217006B2 · kind B2 · utility

19Cited by

11References

8Claims

0Family size

Assignee

Duke University · US

Inventors

Jonathan S. Stamler · Chapel Hill, US
Limin Liu · Simi Valley, US
Alfred Hausladen · Durham, US
Raphael Nudelman · Rehovot, IL

Key dates

Filing date	Sep 24, 2009
Grant date	Jul 10, 2012
Priority date	—
Expiry date	Sep 24, 2029

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Patients needing NO donor therapy or inhibition of pathologically proliferating cells or increased NO bioactivity are treated with a therapeutically effective amount of an inhibitor of glutathione-dependent formaldehyde dehydrogenase.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.